Literature DB >> 19324157

Midterm results for collaborative treatment of pulmonary atresia with intact ventricular septum.

Robert L Hannan1, Jennifer A Zabinsky, Robert M Stanfill, Roque A Ventura, Anthony F Rossi, David G Nykanen, Evan M Zahn, Redmond P Burke.   

Abstract

BACKGROUND: We report a single-institution experience using a collaborative surgical and catheter-based approach to the initial treatment of pulmonary atresia with intact ventricular septum.
METHODS: A retrospective review was conducted of all neonates admitted with pulmonary atresia with intact ventricular septum from 1996 to March 2007.
RESULTS: We identified 24 patients with a mean age at first intervention of 4.5 days with mean follow-up of 6.05 years (range, 1.9 to 12.7 years). Initial palliation was determined by right ventricular size, morphology, and presence or absence of right ventricular-dependent coronary circulation. Initial catheter-based pulmonary valve perforation and valvuloplasty was performed in 41.7% (10 of 24 patients; group A), and 58.3% (14 of 24 patients) had an initial systemic-to-pulmonary artery shunt (group B). Tricuspid valve size was significantly smaller in group B (median z-score, -0.52 group A versus -2.40 group B; p < 0.001). Placement of a shunt after valvuloplasty in group A was required in 70.0% (7 of 10 patients). There was no mortality in group A, and 70.0% (7 of 10 patients) are in a two-ventricle pathway and 30.0% (3 of 10 patients) are in a 1.5-ventricle pathway. Group B had mortality of 14.3% (2 of 14 patients), both within 5 days of surgery. All group B patients remain in a single-ventricle pathway. Overall survival is 91.7% (22 of 24 patients).
CONCLUSIONS: An individualized approach to this complex lesion has good results. If the right ventricle can be safely decompressed and appears usable, the need for a shunt after valvuloplasty does not preclude two-ventricle (or 1.5-ventricle) repair. Anatomy mandating a shunt as initial palliation has substantial early mortality.

Entities:  

Mesh:

Year:  2009        PMID: 19324157     DOI: 10.1016/j.athoracsur.2009.01.040

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  3 in total

1.  Predictors of Mortality in Children with Pulmonary Atresia with Intact Ventricular Septum.

Authors:  Stephanie Grant; David Faraoni; James DiNardo; Kirsten Odegard
Journal:  Pediatr Cardiol       Date:  2017-09-04       Impact factor: 1.655

2.  Long-Term Outcomes After an Individualized Strategy in Patients with Pulmonary Atresia and Intact Ventricular Septum.

Authors:  Jun Muneuchi; Mamie Watanabe; Yuichiro Sugitani; Hirohito Doi; Takashi Furuta; Masaru Kobayashi; Hiroki Ezaki; Yoshie Ochiai
Journal:  Pediatr Cardiol       Date:  2021-09-24       Impact factor: 1.655

3.  Pulmonary Atresia with Intact Ventricular Septum: Midterm Outcomes from a Multicenter Cohort.

Authors:  Ilias Iliopoulos; Christopher W Mastropietro; Saul Flores; Eva Cheung; Venugopal Amula; Monique Radman; David Kwiatkowski; Bao Nguyen Puente; Jason R Buckley; Kiona Y Allen; Rohit Loomba; Karan B Karki; Saurabh Chiwane; Katherine Cashen; Kurt Piggott; Yamini Kapileshwarkar; Keshava Murty Narayana Gowda; Aditya Badheka; Rahul Raman; Huaiyu Zang; John M Costello
Journal:  Pediatr Cardiol       Date:  2022-06-25       Impact factor: 1.655

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.